Indo Rama Synthetics (India)

Quick check

The five things to look at first. Open one for more.

• DebtAdequate safetyRated A- by India Ratings.
• ResultsGrowingIn the Sep 2026 quarter, sales rose 9.8% and profit rose 196% from a year earlier.
• DilutionNo new sharesNo new shares issued in the last year, so existing shareholders' slices were not cut.
• PromotersSteadyThe promoters (founders or parent) own 75% of the company, about the same as in Sep 2025.
• ValuationNormal for this stockThe share trades at 9.1 times its yearly earnings (P/E), pricier than 71% of the time in the last 5 years. Its usual P/E is about 7.

Indo Rama Synthetics (India) against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

• Valuation (P/E)9.1 against a typical 16.7: cheaper than most peers (1st = cheapest).75th of 268
• Sales growth+9.8% against a typical +6.7% from a year earlier.100th of 234
• Profit growth+196% against a typical +12.9% from a year earlier.23rd of 166
• Share price, 3 months+34.6% against a typical −4.3%.17th of 241
• Size₹ 1,942.7 Cr. market value against a typical ₹ 58.7 Cr. (1st = largest).17th of 256

Exchange filings and their impact on the company.

• 23 Oct 2026Investor PresentationHigh impactVery positivePrice −0.1% on 26 Oct
  Q2 profit tripled and debt fell sharply while a Rs 200 cr specialty expansion targets 20% more EBITDA.

  Indo Rama Synthetics shared its Q2 and H1 FY27 investor presentation showing Q2 total income of Rs 1,344 crore up 10%, EBITDA of Rs 118 crore up 46% and profit of Rs 74 crore up 202% from last year. Net debt fell 23.5% to Rs 852 crore and operating cash flow jumped to Rs 329 crore in H1. The company also approved a ~Rs 200 crore specialty filament and fibre expansion at Butibori, expected in CY27, which it says can lift EBITDA by ~20% with payback in under two years.

  Full analysisFiling
• 16 Oct 2026Outcome of Board MeetingMedium impactPositivePrice +3.2% that day
  Board approves Rs 200 cr speciality filament and fibre expansion at Butibori with start-up in 12-18 months.

  Indo Rama Synthetics board on 16 October 2026 approved about Rs 200 crore capex for speciality filament and speciality fibre production at its Butibori plant in Nagpur. The project will be done in the company and its wholly owned subsidiary Indorama Ventures Yarns and is expected to start commercial operations in 12-18 months. It will be funded by a term loan plus internal accruals, adding near-term capex and debt before revenues begin.

  Full analysisFiling
• 16 Oct 2026Outcome of Board MeetingHigh impactVery positivePrice +3.2% that day
  Strong Q2 with tripled profit and sharp debt cut signals much higher earnings and lower leverage ahead.

  Indo Rama Synthetics reported strong Q2 FY27 consolidated results with revenue of Rs 1340.6 cr, up from Rs 1220.6 cr last year, and net profit of Rs 74.1 cr versus Rs 24.6 cr last year. Half-year profit of Rs 137.8 cr is already near last full year's Rs 150.2 cr, with operating margins near 9-10% versus 6% last year. Borrowings fell to Rs 860 cr from Rs 1132 cr in March on strong Rs 328 cr operating cash flow, materially strengthening the balance sheet.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.

Listed companies in the same business.

Om Prakash Lohia

Executive Chairman of the Board, Managing Director

Umesh Kumar Agrawal

Chief Commercial and Financial Officer

Ashok Yadav

Compliance Officer, Company Secretary

Vishal Lohia

Whole-Time Director

Sanjay Thapliyal

Whole-Time Director